School of Medicine
Showing 41-60 of 127 Results
-
Jeffrey Goldberg, MD, PhD
Blumenkranz Smead Professor
Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.
-
Mary Elizabeth Hartnett, MD
Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology
BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.
Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.
Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.
Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology.
Dr. Hartnett's prolific publication record includes 227 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as chair of the research advisory committees for The Macula Society and the Jack McGovern Coats Disease Foundation as well as Chair of the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO). -
Natalie Anne Homer, MD
Assistant Professor of Ophthalmology
BioDr. Homer completed her ophthalmology residency at Massachusetts Eye and Ear Infirmary at Harvard Medical School and subsequently received fellowship training in plastic and reconstructive surgical procedures of the eyelids, orbit, nasolacrimal system and face accredited by the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) at TOC Eye and Face in Austin, TX. She completed an additional fellowship year in facial cosmetic surgery through the American Academy of Cosmetic Surgery (AACS), training in procedures including rhytidectomy (facelift), platysmaplasty (necklift), forehead/brow lift, blepharoplasty (upper and lower eyelid lift) and autologous fat transfer. She served as an assistant professor in the UC Davis Department of Ophthalmology from 2020 – 2022.
Dr. Homer clinically provides comprehensive ophthalmic plastic and reconstructive surgical care to her patients. She also enjoys improving patient confidence and self-esteem through restorative cosmetic facial surgery. In addition to clinical care, Dr. Homer strives to educate and inspire young medical trainees as an assistant professor of ophthalmology. Dr. Homer was the recipient of the UC Davis Ophthalmology Surgical Teaching Award in 2022. Dr. Homer serves on the American Board of Ophthalmology Written Examination Development Committee and is an oral board examiner for the American Society of Ophthalmic Plastic and Reconstructive Surgery.
Dr. Homer has performed research in the areas of orbital oncology, orbital and facial trauma, periorbital infections, eyelid and facial reconstruction, facial nerve palsy, pediatric orbital and adnexal disorders, nasolacrimal surgery, thyroid eye disease, cosmetic and functional surgical outcomes, wound healing, and oculoplastic fellowship education. She has presented her work at national and international conferences. In addition to her scientific work, she published 6 invited articles on topics including the women in cosmetic surgery, ophthalmology advocacy and oculoplastic fellowship training. Administratively, she serves as an Editorial Board Member for the American Journal of Ophthalmology case reports and EyeWiki. -
Yang Hu, MD, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science to design and develop human-centric technologies. Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank. -
Eubee Baughn Koo
Clinical Assistant Professor, Ophthalmology
BioDr. Koo is a board-certified ophthalmologist with the Byers Eye Institute at Stanford Health Care and a clinical assistant professor in the Department of Ophthalmology.
Dr. Koo diagnoses and treats a wide range of eye conditions, such as blepharitis, macular degeneration, diabetic retinopathy, farsightedness, cataracts, and glaucoma. She performs a range of surgical procedures, including cataract surgery, chalazia excisions, and laser glaucoma surgery. Dr. Koo creates a comprehensive, personalized treatment plan for each of her patients.
In addition to her clinical responsibilities, Dr. Koo is involved in the education and oversight of medical students, interns, and Ophthalmology residents spanning all settings from the classroom to the clinic, operating room, and the hospital.
Dr. Koo researches best practices in ophthalmologic care. Her research has included case studies to evaluate treatments in adults and children.
Dr. Koo’s work has been published in peer-reviewed journals, including Retina and the Journal of Pediatric Ophthalmology and Strabismus. She has been invited to moderate and present at regional, national, and international meetings, including the World Ophthalmology Congress. -
Euna Koo, MD
Clinical Associate Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBioDr. Koo is an ophthalmologist specializing in pediatric ophthalmology, retinopathy of prematurity (ROP) and adult strabismus. She received her ophthalmology training at UC San Francisco and then her fellowship training in pediatric ophthalmology and adult strabismus at Boston Children's Hospital affiliated with Harvard Medical School. She has been board certified by the American Board of Ophthalmology since 2016. Her practice reflects her clinical interests in pediatric ophthalmology (strabismus, amblyopia, pediatric cataracts, and ROP) and in adult strabismus.
She utilizes Botox in management of adult and pediatric strabismus. She also uses hidden adjustable sutures in children and adults to optimize alignment of eyes with surgery. Muscles can be adjusted up to 7-10 days after surgery.
She also has an interest in teaching medical students and residents and improving surgical training. -
Edward Korot
Adjunct Clinical Instructor, Ophthalmology
BioI’m a vitreoretinal surgeon guided by the goal of maximally scaling improvements in patients’ lives through technology.
My work involves medical AI validation, guideline development, safety, quantifying model uncertainty, AI-driven pharmaceutical trial recruitment, partner management, and UX research.
Currently, I’m an adjunct faculty at Stanford, and practicing in Michigan. When not working, you can find me doing yoga, practicing drone photography and playing tennis. -
Andrea Lora Kossler, MD, FACS
Assoc Professor of Ophthalmology
Current Research and Scholarly InterestsThyroid Eye Disease
Adenoid Cystic Carcinoma of the Lacrimal Gland
Lacrimal Gland Stimulation for the Treatment of Dry Eyes
Neurostimulation
Orbital Tumors
Floppy Eyelid Syndrome and Obstructive Sleep Apnea -
Scott R. Lambert, MD
Professor of Ophthalmology and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.
-
Wen-Shin Lee, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Wen-Shin Lee, MD, is a Clinical Assistant Professor of Ophthalmology at the Stanford University School of Medicine, and the Clinic Chief and Medical Director of the Byers Eye Institute Tri-Valley.
Dr. Lee is a fellowship trained, board certified ophthalmologist with expertise in the medical and surgical management of glaucoma, cataracts, and anterior segment disease. Working with patients to provide individually tailored treatment plans, he incorporates the full spectrum of conventional and minimally invasive glaucoma surgeries. He also performs complex and refractive cataract surgery utilizing advanced technology intraocular lenses. His goal is to provide the highest level of care to each patient with evidence-based medicine and cutting-edge technology.
In addition to his clinical practice, Dr. Lee is actively involved in clinical research and education at the Stanford University School of Medicine. He is a principal investigator and co-investigator on multiple clinical trials and research studies with a focus on glaucoma. He is the resident glaucoma rotation director for the Stanford ophthalmology residency and co-director of the Bay Area Ophthalmology Course. He has developed and leads microsurgical training programs for medical students, residents, and fellows at Stanford. In addition, he serves on the Education Committee and Clinical Competency Committee for the Stanford Department of Ophthalmology.
Dr. Lee was educated at the University of California, Berkeley, where he graduated summa cum laude with a degree in molecular and cell biology. He then received his medical degree at Harvard Medical School, followed by his ophthalmology residency at the Stanford University School of Medicine, and glaucoma fellowship at the Jules Stein Eye Institute at UCLA. Upon completion of his training he joined the clinical faculty at Stanford.
Dr. Lee serves as the Clinic Chief and Medical Director of the Byers Eye Institute Tri-Valley, where his goal is to deliver world class eye care to the Tri-Valley region and beyond. -
Theodore Leng, MD, FACS
Associate Professor of Ophthalmology and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult MSD)
Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cellular, biologic and laser-based therapies for macular degeneration. He also has an active program in imaging informatics and deep learning to perform big data analyses of retinal scans to identify patients who are at risk for retinal disease deterioration. The end goal is earlier detection and rapid treatment to maximize visual outcomes.
Dr. Leng is considered a leading expert on optical coherence tomography (OCT) and OCT-based angiography (OCTA), a non-invasive and non-contact imaging technique for the retina. He is also considered a key opinion leader in artificial intelligence and data science.
